Calcitonin Linked to Cancer Risk, EMA Warns
10:15 EDT 20 Jul 2012 | Medscape
The European version of the FDA is recommending market withdrawal of calcitonin nasal spray, used to treat osteoporosis. Two brand-name versions are marketed in the United States. News Alerts
Original Article: Calcitonin Linked to Cancer Risk, EMA Warns
More From BioPortfolio on "Calcitonin Linked to Cancer Risk, EMA Warns"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
